EMEA-001460-PIP01-13-M02

Key facts

Invented name
Genvoya
Active substance
  • elvitegravir
  • cobicistat
  • emtricitabine
  • tenofovir alafenamide
Therapeutic area
Infectious diseases
Decision number
P/0211/2017
PIP number
EMEA-001460-PIP01-13-M02
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of human immunodeficiency virus (HIV-1) infection
Route(s) of administration
Oral use
Contact for public enquiries
Gilead Sciences International Ltd
United Kingdom
Tel. +44 (0)1223 897300
E-mail: regulatory.pip@gilead.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating